drugset / Trial / NCT05664633

The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures

NCT05664633

Phase 1/2 Withdrawn West Virginia University
RandomizedParallel-groupDouble-blindTreatment

Summary

The Investigator will perform a single-institution randomized double-blinded controlled trial comparing intraoperative Sugammadex vs. standard dose of glycopyrrolate/neostigmine combination for participants undergoing a total vaginal hysterectomy with or without pelvic organ prolapse procedures under general endotracheal anesthesia.

Timeline

Start
2023-08
Primary completion
2024-06
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sugammadex Other / unclassified 4 mg/kg